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and be difficult to diagnose. It is characterized by late onset, slow progression and high variability in morphologic and functional
alterations. Diagnostic evaluation should include careful ophthalmoscopy and imaging studies. The typical ophthalmoscopic
findings are bilateral, asymmetric, foveal or perifoveal, yellow, solitary, round to oval elevated subretinal lesions, often with central
pigmentation. The lesions characteristically demonstrate increased autofluorescence and hypofluorescent lesions surrounded by
irregular annular hyperfluorescence on fluorescein angiography. Optical coherence tomography studies demonstrate homogenous
or heterogeneous hyperreflective material between the retinal pigment epithelium and the neurosensory retina. The visual
prognosis is generally favorable, but visual loss can occur from chorioretinal atrophy and choroidal neovascularization.
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Adult-onset foveomacular vitelliform dystrophy (AOFVD)
is a relatively uncommon macular disease first described by
Gass in 1974. 1 It generally presents in the fourth to sixth dec-
ades of life in patients who are visually asymptomatic or have
mild blurring of vision, small central or paracentral scotomas,
or mild metamorphopsia.2 It is often discovered incidentally
on routine examinations. Generally, the visual loss is slowly
progressive, but almost all patients retain reading vision in
at least one eye throughout their lives.
AOFVD is a clinically heterogeneous disease displaying
variability in the size, shape, pigmentary changes, and distri-
bution of macular lesions.3,4 The typical patient has bilateral,
asymmetric, foveal or perifoveal, yellow, solitary, round to
oval elevated subretinal lesions, often with central pigmenta-
tion. The various descriptions in the literature do not makefor an easy diagnostic approach, and this disease is often
confused with other pigment epithelial alterations.5,6 Most
often, AOFVD is misdiagnosed as age-related macular
degeneration, but it can also mimic Best disease. When these
patients are referred to a retina specialist for evaluation, few
of them are suspected of having AOFVD.
It is therefore important to carefully define the ophthalmo-
scopic and imaging characteristics of this maculopathy to im-
prove the diagnostic accuracy. This review will discuss
different imaging modalities and associated findings that
are characteristic of AOFVD.Clinical examination findings
AOFVD is generally characterized by mild visual loss. In
one study of 21 eyes, best-corrected visual acuity ranged
from 20/25 to 20/400, with a mean visual acuity of 20/50. 6e:
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40 and 20/63. Only 4 eyes were worse than 20/63.2 Other
studies showed similar distributions.7
Renner et al.8 found that 38 of 75 eyes had normal color
testing. The other 37 eyes showed nonspecific errors of var-
iable severity without any typical axis of confusion. Upon vi-
sual field testing, 28 of 53 eyes had normal visual fields,
whereas 25 demonstrated a central scotoma. An absolute
scotoma was observed in only four eyes.
On ophthalmoscopy, AOFVD is characterized by various
patterns of unilateral or bilateral, yellow, round to oval
elevated subretinal lesions, that often contain a central small,
pigmented spot (Fig. 1). Lesions can be barely detectable or
up to one disk area in size, are located at the fovea or the
perifoveal region, and may be surrounded by small drusen.2,7Figure 1. Adult-onset foveomacular vitelliform dystrophy in a 64-year-old man
macular degeneration. (A and B) Color fundus photographs show bilateral, vit
white spots surrounded by rings of darker material bordered by mott
hypoautofluorescence surrounded by a ring of hyperfluorescence. (G and H)
shows mottled foveal hyperfluorescence with late staining without leakage (I: O
spectral-domain optical coherence tomography (SD-OCT) OD shows a disrup
photoreceptor layer that overlies a subretinal hyperreflective dome-shaped le
superior macula), showing a mottled ELM and inner segment/outer segme
material. The arrow points to an optically empty zone superiorly within the suBilateral lesions were present in 29 of 43 patients in one
study9 and in 11 of 49 patients in another.7 Another
evaluation of 8 patients with AOFVD revealed the presence
of a central small, pigmented spot bilaterally in 6 of the 8 pa-
tients. In 2 eyes, there were several smaller yellow flecks close
to the central lesion and the yellow material was found to
fade gradually from the center of the lesion toward its periph-
ery.10 Importantly, patients may also present later in the
course of the disease when the lesions take on different clin-
ical characteristics. Eventually, the lesions may fade, leaving
an area of RPE alteration or atrophy.
Complications of the disease that can cause visual loss
include choroidal neovascularization in up to one-third of
patients, geographic atrophy, and outer retinal atrophy.11–13
Abrupt visual changes may occur as a result of new onsetwho presented with blurry vision, previously misdiagnosed as age-related
elliform, circular, foveal lesions. (C and D) Infrared imaging shows central
led outlines of white material. (E and F) The lesions have central
Red free frames show the central white spots. Fluorescein angiography
D at 01:02, J: OS at 00:30, K: OD at 04:38, L: OS at 4:48). (M) Horizontal
ted external limiting membrane (ELM) and a mottled and hyperreflective
sion. (N) Vertical SD-OCT scan of the left eye (right side of the image is
nt junction, which overlies a heterogeneously hyperreflective subretinal
bretinal space, signifying a subtle pseudohypopyon.
Figure 2. A relatively subtle case of adult-onset foveomacular vitelliform
dystrophy in a 74-year-old woman previously misdiagnosed as age-
related macular degeneration, who presented with blurry vision. (A and B)
Fundus color photographs show bilateral yellow–orange lesions with
central pigmented dots. (C and D) Early frames of fluorescein angiogra-
phy show central hypofluorescence with rings of irregular hyperfluores-
cence, that in later frames (E and F) stain but do not leak. (G and H)
Spectral-domain optical coherence tomography shows subfoveal debris
in both eyes.
106 S. Grob et al.choroidal neovascularization, which presents with the typical
findings. On exam, there are no findings suggestive of chori-
oretinal inflammation, and there is no evidence of subretinal
fluid or hemorrhage in the absence of choroidal neovascular-
ization. Also, abnormalities outside of the macula are rare.7
AOFVD differs from vitelliform dystrophy or Best disease
by many characteristics. The lesions in AOFVD are usually
small, but when they are larger, they can mimic those seen
in Best disease. AOFVD also has a later onset (40–70 years
of age), presents with moderate symptoms, and has a normal
or mildly subnormal electrooculogram (EOG). In Best dis-
ease, the onset is usually early (often before age of 30) and
patients can maintain relatively good vision even with a large
macular lesion throughout the course of the disease. Unlike
AOFVD, Best disease is always associated with an abnormal
EOG. Additionally, although most people with Best disease
have a single foveal lesion, there are numerous reports of pa-
tients that have multiple vitelliform lesions.14–18
Autofluorescence
The condition is characterized by increased autofluores-
cence within the foveal yellow lesion, reported in 76% of pa-
tients in one study.8 It has been previously established that
autofluorescence is derived from lipofuscin in the retinal pig-
ment epithelium (RPE) 19. The high level of autofluorescence
seen in AOFVD patients indicates an abnormal accumulation
of lipofuscin, which is consistent with histologic studies (dis-
cussed later). (Fig. 1)
Fluorescein angiography
Fluorescein angiography (FA) demonstrates an early cen-
tral hypofluorescent spot surrounded by an irregular ring of
hyperfluorescence2,7,9 (Figs. 1 and 2). The central area of
hypofluorescence corresponds with the yellow lesion seen
clinically (whitish material seen on red free photographs). In
the later frames,2,7 the lesion can persist as a hypofluorescent
spot with no staining or show staining of variable intensity
without leakage.2 One study showed 16 of 21 eyes with cen-
tral staining in the late stages with the other 5 eyes demon-
strating persistent hypofluorescence.2 The surrounding ring
of hyperfluorescence often increases in intensity in later
images. One study showed this phenomenon in 65 of 72
eyes.9 In contrast, there are reports of patients without the
classic hypofluorescent spot and with only well-delineated
central hyperfluorescence.9 Therefore, it is important to note
the variability in FA findings.
Indocyanine green angiography
Indocyanine green angiography (ICG) in patients with
AOFVD reveals no abnormality in choroidal perfusion. One
study discussed the two main characteristic features: a central
hypofluorescent spot, which was evident in the early frames
up to the late phases, and an irregular, round hyperfluores-
cent ring surrounding the central spot 10. The central hypoflu-
orescent spot blocked the underlying choroidal vessels and
seemed to correlate well with the central pigmented spot
noted on biomicroscopy. This central dark spot was inter-
preted as the consequence of the RPE clump that was de-
scribed by Gass1 and Jaffe and Schatz20 in their histologicalanalysis of AOFVD. In addition, there was no difference in
ICG pattern between cases, even comparing patients with
and without a central pigmented spot on clinical exam. There-
fore, all patients may have this central pigmented clump, but
in some patients the pigmented clump might be covered by
the yellow material and thus, not visible on exam.10
The hyperfluorescent ring surrounding the central hypoflu-
orescent spot was visible on ICG after only a few minutes. It
increased in intensity but not in size and it was detectable up
to the late phase during the reduction of the background
fluorescence due to the dye out-flow.10Optical coherence tomography
The exact location of the vitelliform material in AOFVD
was not fully elucidated until the development of optical
coherence tomography (OCT) imaging. Previous reports that
subjectively analyzed color or monochromatic stereoscopic
photos described the material as subretinal,1,21 sometimes
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development of OCT was the location fully elucidated. OCT
is a noninvasive technique that provides optical cross-sec-
tional images of the retina and morphologic information sim-
ilar to that obtained from histologic sections.
Using time-domain (first generation) OCT, Benhamou
et al.2, suggested that the vitelliform material was located be-
tween the sensory retina and the RPE. In this study, 16 of 21
eyes showed the yellowish material as a highly reflective area
located between the hyporeflective photoreceptor layer and
the hyperreflective RPE. In most cases, the RPE was more
reflective than the subretinal material. These eyes also showed
late staining on FA without leakage. The other five eyes did
not have late staining, and their OCTs showed the macular le-
sions as focal thickening of the RPE with no identifiable over-
lying hyperreflective material. In all cases with underlying
hyperreflective material, the macula was raised by the material
and showed overlying retinal thinning. In 20 eyes, there was a
disappearance of the normal foveal depression from the sub-
foveal material or RPE thickening. All 21 eyes were without
RPE detachment, retinal thickening or serous detachment.2
The finding of five eyes without late staining on FA and no
subretinal material, was explained by different stages of
AOFVD and the differences in morphology that present at
different stages. It has been shown that, with time, the sub-
retinal material progresses slowly toward fragmentation
and then disappears. The disappearance of this material is
followed by the occurrence of atrophic RPE lesions and the
appearance of pigmented spots.22,24
Benhamou et al.25 confirmed these findings in a case re-
port using third generation (3G) time-domain OCT, locating
the vitelliform accumulation between the junction of the pho-
toreceptor inner and outer segments (IS/OS interface) and
the RPE/choriocapillaries complex.25 However, Pierro et al.9
had previously reported that the AOFVD lesions were lo-
cated in the sub-RPE space, which created controversy as
to the location of the lesions.
Further studies with improved imaging techniques con-
firmed the location of the deposits and resolved the previous
confusion. Compared to time-domain OCT, spectral-domain
OCT technology greatly improves the resolution and image
acquisition speed.26 A recent spectral-domain OCT study
evaluating the topographic features of AOFVD was consis-
tent with Benhamou’s study and showed the vitelliform mate-
rial as a highly reflective dome-shaped lesion located
between the photoreceptor layer and the RPE.7 The subreti-
nal material was shown to be homogenous in 14/60 eyes and
heterogeneous in 36/60 eyes. This study also found OCT
characteristics that included hyper-reflective clumps within
the outer plexiform and outer nuclear layers in 28/60 eyes,
a highly reflective photoreceptor IS/OS interface in 9/60
eyes, disappearance of a well-defined Verhoeff membrane
(the optical layer between the RPE and the photoreceptor
IS/OS interface) over the vitelliform lesion in 20/60 eyes,
and irregularity to the RPE with hyperreflective mottling in
14/60 eyes. These findings suggested the earliest alteration
in the subretinal environment in AOFVD involves the layer be-
tween the RPE and IS/OS interface with the accumulation of
vitelliform material. Interestingly, the RPE may demonstrate
hypertrophy and sub-RPE deposits.7
This same group had previously suggested a four-stage
classification for AOFVD based on the one that wasestablished for Best vitelliform macular dystrophy. These
stages included vitelliform, pseudohypopyon, vitelliruptive
and atrophic, in progressive order27 The vitelliform stage is
the classic dome-like lesion with subretinal vitelliform mate-
rial. In the pseudohypopyon stage, the vitelliform material
settles inferiorly within the subretinal space, to create an opti-
cally empty zone superiorly, with hyperreflective material
inferiorly, and a horizontal demarcation at the interface.
The vitelliruptive stage is characterized by collapse of the
dome-like shape into a lesion with heterogeneous vitelliform
material and hyperreflective clumps within the inner retina.
Finally, spectral domain OCT is also able to visualize chorio-
retinal atrophy, characterized by loss of the outer retina
and varying degrees of thinning/mottling and loss of the
RPE and choriocapillaris. This would suggest the final
atrophic stage.7
Pierro et al.9 showed a correlation between the thinning of
the neurosensory retina over the vitelliform lesion and poor
visual acuity (P = 0.001). Visual acuity was also found to wor-
sen in eyes that progressed through the four stages dis-
cussed above, in eyes with disruption in the IS/OS
interface, and in those with changes in lesion reflectivity on
spectral-domain OCT (P = 0.03).28 Also, as eyes progressed
from one stage to the next on the continuum, mean central
macular thickness (P = 0.004), maximal thickness of the lesion
(P = 0.001), and maximal width of the lesion showed signifi-
cant changes (P = 0.04).28
Querques et al.27 also previously correlated OCT findings
in patients with AOFVD with the extent of visual function
impairment using microperimetry, a relatively new psycho-
physical method that makes it possible to compare retinal
morphologic features with retinal function by simultaneously
testing central retinal sensitivity and fixation patterns in rela-
tion to the fundus image. The study found that reduced thick-
ness of the neurosensory retina at the foveola and reduced
visual acuity were correlated with advanced stage of the dis-
ease (P = 0.001 and P = 0.0062, respectively). Moreover,
worse visual acuity correlated with reduced thickness of the
foveal neurosensory retina (P = 0.02), was associated with
the development of an absolute scotoma (P = 0.03), eccentric
fixation (P = 0.01), and unstable fixation (P = 0.03).
In comparing AOFVD to Best disease, reports showed that
Best disease is more often being associated with serous neu-
rosensory detachments on OCT.9 A recent study29 compared
patients with AOFVD to those with age-related macular
degeneration (AMD) using spectral domain OCT. Macular
choroidal thickness in 38 patients with AOFVD, neovascular
AMD or nonneovascular AMD was evaluated using enhanced
depth imaging optical coherence tomography (EDI-OCT).
Subfoveal choroidal thickness in AOFVD patients with subret-
inal fluid significantly increased (P = 0.001) compared with
that of neovascular AMD and nonneovascular AMD, as well
as that of normal controls (P = 0.001). This finding was inter-
esting since choroidal thinning is usually observed in advanced
AMD. Therefore, choroidal thickness may be a measurement
to help differentiate between AMD and AOFVD.29Electrophysiologic studies
Electrophysiologic testing, both electrooculography
(EOG) and electroretinography (ERG), is typically within nor-
108 S. Grob et al.mal limits in patients with AOFVD. The EOGs of eyes with
AOFVD tend to be normal but can also be mildly subnormal,
whereas the EOG in Best disease patients is always abnormal.
Renner et al.8 evaluated 21 eyes with AOFVD using EOG.
A normal light increase (P160%) was present in 6 patients in
both eyes and in 3 patients in one eye. A slightly reduced
light increase (149–155%) was observed in 2 patients in both
eyes and in two other patients in one eye. Patients with a def-
inite yellow macular lesion were more likely to have the sub-
normal EOG response.
Additionally, a full field ERG was recorded in 43 eyes. The
b-wave amplitude of the maximum cone response was
slightly reduced in 12 eyes, as was the single flash cone re-
sponse in 18 eyes. The 30-Hz flicker response was reduced
in the majority of eyes (31 eyes, 72%) 8. Most prior studies,
however, reported normal ERGs23,30–35 in patients with
AOFVD.Histopathology
A number of clinicopathologic studies in eyes with AOFVD
have shown massive accumulation of lipofuscin pigments
within the RPE in the macula. Evidence of RPE and photore-
ceptor loss, as well as infiltration of these layers with lipofus-
cin pigment containing macrophages have also been
described.1,4,20,36
Patrinely et al.4 performed detailed pathologic studies of
two postmortem eyes from a 61 year old woman with
AOFVD. The findings were most significant for abnormalities
found within the RPE and photoreceptor layers. By light
microscopy, marked focal atrophy of the pigment epithelial
cells in the foveolar area was bordered by hypertrophic
RPE. Interpose between the atrophic RPE and Bruch’s mem-
brane was a scattered eosinophilic, fusiform collagenous pla-
ques. The sensory retina overlying the deranged RPE
displayed marked atrophy of the outer nuclear layer with loss
of photoreceptor inner and outer segments. Lipofuscin pig-
ment-laden macrophages containing periodic acid-Schiff-
positive material had migrated into the atrophic, outer sensory
retina. Ultraviolet fluorescent microscopy demonstrated mas-
sive accumulation of lipofuscin pigment within the macular
RPE as well as within macrophages in the atrophic outer ret-
ina. By scanning electron microscopy, a confluent area of flat-
tened, atrophic retinal pigment epithelial cells was rimmed
by taller, hypertrophic RPE cells. By transmission electron
microscopy, the pigment epithelial cells contained myriad lip-
ofuscin granules. Bruch’s membrane and the intercapillary
pillars were slightly thickened and the choriocapillaris was
patent.4Genetics of AOFVD
The inheritance of AOFVD is variable – both autosomal
dominant1,3,11,33,37 and sporadic cases have been
reported.6,22,30 Initially, Gass presumed an autosomal domi-
nant inheritance.1 There are two descriptions of three-gener-
ation pedigrees unequivocally supporting an autosomal
dominant inheritance pattern.11,38 However, many patients
present as isolated cases with unremarkable family histories.8
Since the condition is often detected incidentally, it may be
necessary to carefully examine asymptomatic family
members.Several genes have been associated with AOFVD. First,
BEST1 mutations are most commonly associated with Best
vitelliform macular dystrophy, but the gene has been impli-
cated in a broad spectrum of ocular phenotypes. BEST1
mutations account for approximately half of Best vitelliform
macular dystrophy cases. The bestrophin 1 protein, ex-
pressed in the RPE, is a chloride channel involved in intracel-
lular calcium signaling.39–42 Mutations in this gene have also
been associated with AOFVD in up to 25% of patients.43–45
Second, PRPH2/RDS was identified in 1991 and has also been
associated with a variety of macular dystrophies, cone and
rod dystrophies, and retinitis pigmentosa.46–56 The RDS-Per-
ipherin protein is expressed in rod and cone photoreceptors
and plays a pivotal role in the formation and stability of disks
forming a heterodimer in rods and rod outer segment pro-
tein 1.46–48 Over 90 different mutations in this gene have
been reported and approximately 20 of them have been
associated with AOFVD, accounting for a small percentage
of cases (2–18% of patients)52,54,55. In a study searching for
mutations in the BEST1 gene and PRPH2 gene in 19 patients
with AOFVD, 2/19 (10.5%) of the cases had a PRPH2 muta-
tion, and none carried a BEST1 mutation. The 2 patients
found to have PRPH2 mutations had family histories of
AOFVD.57 However, there were three other patients with
family histories of AOFVD where mutations were not
identified.
Renner et al.3 examined the DNA samples of 21 patients
for mutations in BEST1 (n = 11) or PRPH2/RDS (n = 10). A dis-
ease-associated sequence alteration was detected in only
one patient, however. This patient carried a 17 base pair
deletion in exon 2 (609_625del17) of the PRPH2/RDS. The
mutation results in a frameshift in codon 203 (Arg203fs) and
leads to premature translation termination eight codons
downstream. This patient had central yellow lesions in both
eyes.8 Several other reports have also shown that AOFVD
can be associated with mutations in PRPH2/RDS.50,52,58
Because of a highly variable penetrance and expressivity
and the controversy on mechanism of inheritance (sporadic
versus autosomal dominant), there is difficulty with genetic
counseling. However, family members can generally be reas-
sured given the good visual prognosis in the majority of
patients.Conclusion
In summary, AOFVD is characterized by late onset, slow
progression and high variability in morphologic and func-
tional alterations. The diagnostic evaluation should include
careful ophthalmoscopy and imaging studies. Imaging of
AOFVD characteristically shows a lesion with increased auto-
fluorescence, central hypofluorescence with a surrounding
irregular hyperfluorescent ring on fluorescein angiogram,
and a nonfluorescent spot with surrounding irregular, round
hyperfluorescence on ICG. Spectral domain OCT shows accu-
mulation of hyperreflective material between the neurosen-
sory retina and the RPE, and is also capable of
demonstrating other findings such as focal chorioretinal atro-
phy. AOFVD is a potentially difficult diagnosis to make, but
multimodal imaging with the aforementioned modalities will
aid in the differentiation of this maculopathy from other
conditions.
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